mercredi 3 juin 2009

Ranpirnase and Doxorubicin Form Effective Second Line Treatment for Malignant Mesothelioma

"Ranpirnase and Doxorubicin Form Effective Second Line Treatment for Malignant Mesothelioma
read more"
(2009-6-4)
Read more...